Common sense, the lower the share price the lower the settlement. Common sense, the lower the share price the more difficult to battle in court. Common sense, the lower the share price, the more pressure shareholders urge to settle. Common sense, the lower the share price, the more difficult to create newer competing products. Common sense, the lower the share price the more difficult to raise capital and more dilution. Common sense, Johnson and Johnson has a hand in the current share price reduction. Common sense, I believe Pharmatech goes after Johnson and Johnson's throat for the maximum settlement.